GalaxyOne platform launched on 6 October 2025, combining cash, crypto and equities in a single app. All details.GalaxyOne platform launched on 6 October 2025, combining cash, crypto and equities in a single app. All details.

GalaxyOne platform launches unified crypto and stock trading app

GalaxyOne platform launched on 6 October 2025, combining cash, crypto and equities in a single app. The product offers a 4% APY cash account that is FDIC insured, crypto custody and trading, and zero-commission trading on more than 2,000 U.S. stocks and ETFs.

What is the galaxyone platform?

GalaxyOne is Galaxy Digital’s new unified trading app that brings together cash, crypto and equities in one account.

The product targets retail users across all U.S. states who pass KYC checks, while leveraging Galaxy’s institutional infrastructure for custody and asset transfers.

In this context, the platform aims to simplify portfolio management by consolidating balances and transactional capabilities under a single user interface.

How does galaxyone crypto trading and galaxyone stock trading work?

At launch users can buy, hold, and transfer bitcoin, ether and Solana and Paxos Gold. The platform also supports fractional trading and offers commission-free trades on many U.S. stocks and ETFs.

Users can move funds and assets on and off the platform, and Galaxy’s custody arrangements underpin the crypto custody and settlement processes.

What yields and cash products are available — galaxyone 4 percent apy and Galaxy Premium Yield Note?

The app offers a 4% APY high-yield cash account that the company says is FDIC insured for eligible balances. Separately, Galaxy offers a Galaxy Premium Yield Note paying 8% APY, but this note is available only to accredited investors and is not FDIC insured.

The yield note is backed by Galaxy’s institutional lending business, and it should be noted that its terms and eligibility differ from the insured cash product.

Which assets and fees should users expect — galaxyone bitcoin ether solana and galaxyone zero commission stocks?

GalaxyOne lists major tokens and tokenized gold via Paxos Gold. Equity trading covers over 2,000 U.S. stocks and ETFs with zero-commission trading for standard orders.

However, some advanced services or specific instruments may carry fees; users should review the platform’s fee schedule and disclosures before trading.

Who benefits — retail traders, institutions or both?

Both. Retail users gain consolidated balances and a simple interface for moving between cash, stocks and crypto. Institutional users benefit from Galaxy’s custody infrastructure and settlement capabilities — a setup designed to bridge retail convenience and institutional-grade operations.

What are the regulatory and custody considerations?

Galaxy says certain cash balances are FDIC insured through partner banks, while crypto assets are held in custody arrangements.

The Premium Yield Note is explicitly not FDIC insured and is offered only to accredited investors under applicable U.S. securities rules, highlighting distinct regulatory treatments across product lines.

Background and acquisition

Galaxy acquired the Fierce app in December 2024 for $12.5 million, and the former Fierce CEO, Rob Cornish, joined Galaxy as CTO. The original Fierce development team now contributes to GalaxyOne’s product development, according to Galaxy’s quarterly report.

In practical use, a retail saver could park idle cash in the 4% APY account while keeping a portion of capital in fractional equities and listed tokens for faster rebalancing without moving between multiple platforms.

Wealth managers I’ve worked with value the consolidated custody reporting: it reduces reconciliation time by consolidating bank and wallet statements in one dashboard.

Traders moving between cash and crypto during volatile sessions benefit from unified settlement rails that can shave minutes off transfer windows compared with coordinating multiple custodians.

For additional context on the product launch and features, see Galaxy’s official announcement: GalaxyOne Launches: High-Yield Cash, Crypto & Stocks in One Platform | Galaxy.

For an explanation of FDIC insurance coverage and limits, refer to the FDIC’s guidance on what FDIC insurance covers: FDIC — Deposit Insurance Overview.

Market Opportunity
RWAX Logo
RWAX Price(APP)
$0.0001417
$0.0001417$0.0001417
+0.99%
USD
RWAX (APP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26